When this insight was extrapolated to in vivo orthotopic and relapsed 143B osteosarcoma models, IL11-PDOX showcased a pronounced suppressive action against tumor proliferation and lung metastasis compared to standalone DOX treatment. The gene discussed is IL11; the disease is osteosarcoma.